Erfahrungsheilkunde 2014; 63(2): 93-99
DOI: 10.1055/s-0033-1357626
Wissen
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

TSH − Physiologie, Funktionsstörungen und Einflussfaktoren auf die Referenzwerte

Eine Laborübersicht
Johannes W. Dietrich
Further Information

Publication History

Publication Date:
28 April 2014 (online)

Zusammenfassung

Die Bestimmung des TSH-Spiegels ist die wichtigste Methode zur Untersuchung der Schilddrüsen-Homöostase. Wir sind daran gewöhnt, dass ein erhöhter TSH-Spiegel für eine Hypothyreose spricht und ein erniedrigter TSH-Spiegel für eine Überversorgung mit Schilddrüsenhormonen. Trotz der inversen Beziehung zwischen FT4- und Thyreotropin-Konzentration gilt dies jedoch nicht immer. Auffällige TSH-Werte oder eine Diskordanz zwischen Klinik und Laboruntersuchung erfordern daher weitere Analysen, insbesondere die Bestimmung freier Schilddrüsenhormone.

Die Übersicht erläutert Physiologie und Funktionsstörungen von TSH sowie mögliche Faktoren, die die Laborergebnisse beeinflussen. Es werden Hinweise zu den Referenzbereichen gegeben, aus denen therapeutische Konsequenzen abgeleitet werden können.

Abstract

Determination of TSH levels is the most important method for diagnostic evaluation of thyroid homeostasis. By virtue of the inverse correlation of FT4 and thyrotropin levels a single TSH determination is sufficient for screening purposes. In cases of suspicious TSH levels or discordance among clinical presentation and laboratory results additional investigations are necessary, first of all determination of free thyroid hormones.

The overview explains the physiology and dysfunctions of TSH as well as possible factors, which influence the laboratory results. Therapeutic consequences can be derived from the reference ranges which are presented.

 
  • Literatur

  • 1 Dietrich JW. Thyreotoxische Krise [Thyroid storm]. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2012; 107: 448-453
  • 2 Wiersinga WM. Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nature reviews 2014; [in Press]
  • 3 Spencer CA, Schwarzbein D, Guttler RB et al. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. The Journal of clinical endocrinology and metabolism 1993; 76: 494-498
  • 4 Dietrich JW, Landgrafe G, Fotiadou EH. TSH and thyrotropic agonists: key actors in thyroid homeostasis. Journal of thyroid research 2012; 2012 351864
  • 5 Hoermann R, Midgley JE, Larisch R et al. Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?. European journal of endocrinology/European Federation of Endocrine Societies 2013; 168: 271-280
  • 6 Midgley JE, Hoermann R, Larisch R, Dietrich JW. Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model. Journal of clinical pathology 2013; 66: 335-342
  • 7 McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Hormones and behavior 2003; 43: 2-15
  • 8 Gärtner R. Schilddrüsenhormontherapie [Thyroid hormone treatment]. Dtsch Med Wochenschr 2013; 138: 1413-1420 quiz 1421−1414
  • 9 Karga H, Giagourta I, Papaioannou G et al. Transient changes in thyroid functions tests after zoledronic acid infusion. Endocrine journal 2011; 58: 969-977
  • 10 Abdulrahman RM, Verloop H, Hoftijzer H et al. Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. The Journal of clinical endocrinology and metabolism 2010; 95: 3758-3762
  • 11 Perret G, Yin YL, Nicolas P et al. In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5’-deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol. Fundamental & clinical pharmacology 1991; 5: 583-593
  • 12 Cunha Lima ST, Merrigan TL, Rodrigues ED. Synthetic and Plant Derived Thyroid Hormone Analogs. In: Ward L, ed Thyroid and Parathyroid Diseases − New Insights into Some Old and Some New Issues. Rijeka: InTech; 2012. http://j.mp/1fWiU38
  • 13 Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126
  • 14 Fontes R, Coeli CR, Aguiar F et al. Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects. Thyroid research 2013; 6: 13
  • 15 Dietrich JW, Brisseau K, Boehm BO. [Absorption, transport and bio-availability of iodothyronines]. Dtsch Med Wochenschr 2008; 133: 1644-1648
  • 16 Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 2002; 23: 370-391
  • 17 Laurberg P, Andersen S, Carle A et al. The TSH upper reference limit: where are we at?. Nature reviews 2011; 7: 232-239
  • 18 Goede SL, Leow MK, Smit JW, Dietrich JW. A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications. Mathematical biosciences 2014; 249: 1-7